TIMP2 and non-small cell lung carcinoma: Conversely, transfection with a miR-130b inhibitor upregulated TIMP-2 protein expression in NCI-H1755 cells (Fig. 3E,F), indicating that TIMP-2 was a target of miR-130b in NSCLC cells.